UDISAP 300
Normalizes Liver Enzymes in Hepatitis
Udisap 300 helps in the treatment and management of fatty liver conditions associated with diabetes, hyperlipidemia, and obesity.
Ursodeoxycholic Acid (UDCA): A secondary bile acid that helps in regulating liver fat metabolism, reducing liver enzyme levels, and improving liver function.
It addresses bile-related digestive issues, helps alleviate symptoms like epigastric pain, nausea, and vomiting, and is beneficial in managing non-alcoholic fatty liver disease (NAFLD), insulin resistance, and bile reflux gastritis. This medication provides comprehensive support for liver health by reducing acid on gastric mucosal damage.